Anti-apoptotic role of peroxiredoxin III in cervical cancer cells

FEBS Open Bio

Volumn 3, Issue , 2013, Pages 51-54

  Li, Lianqin ^a   Zhang, Yong Gang ^a   Chen, Chun Ling ^a  

^a TSINGHUA UNIVERSITY YUQUAN HOSPITAL   (China)

Author keywords

Apoptosis; Cervical cancer; Oxidative stress; Peroxiredoxin III

Indexed keywords

BETA ACTIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PEROXIREDOXIN 5; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL COUNT; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX EPITHELIUM;

EID: 84872005986     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.12.002     Document Type: Article

References (21)

1. Wonsey D.R., Zeller K.I., Dang C.V. The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. Proc. Natl. Acad. Sci. USA. 2002, 99:6649-6654.
2. Hattori F., Murayama N., Noshita T., Oikawa S. Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. J. Neurochem. 2003, 86:860-868.
3. Matsushima S., Ide T., Yamato M., Matsusaka H., Hattori F., Ikeuchi M., Kubota T., Sunagawa K., Hasegawa Y., Kurihara T., Oikawa S., Kinugawa S., Tsutsui H. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2006, 113:1779-1786.
4. Choi J.H., Kim T.N., Kim S., Baek S.H., Kim J.H., Lee S.R., Kim J.R. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res. 2002, 22:3331-3335.
5. Park J.H., Kim Y.S., Lee H.L., Shim J.Y., Lee K.S., Oh Y.J., Shin S.S., Choi Y.H., Park K.J., Park R.W., Hwang S.C. Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 2006, 11:269-275.
6. Karihtala P., Mäntyniemi A., Kang S.W., Kinnula V.L., Soini Y. Peroxiredoxins in breast carcinoma. Clin. Cancer Res. 2003, 9:3418-3424.
7. Kinnula V.L., Lehtonen S., Sormunen R., Kaarteenaho-Wiik R., Kang S.W., Rhee S.G., Soini Y. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J. Pathol. 2002, 196:316-323.
8. Kim K., Yu M., Han S., Oh I., Choi Y.J., Kim S., Yoon K., Jung M., Choe W. Expression of human peroxiredoxin isoforms in response to cervical carcinogenesis. Oncol. Rep. 2009, 21:1391-1396.
9. J.X. Hu, Q. Gao, L. Li. (in press) Peroxiredoxin 3 is a novel marker for cell proliferation in cervical cancerBiomed. Rep. Doi: 10.3892/br.2012.43.
10. Li L., Shoji W., Oshima H., Obinata M., Fukumoto M., Kanno N. Crucial role of peroxiredoxin III in placental antioxidant defense of mice. FEBS Lett. 2008, 582:2431-2434.
11. Li L., Kaifu T., Obinata M., Takai T. Peroxiredoxin III-deficiency sensitizes macrophages to oxidative stress. J. Biochem. 2009, 145:425-427.
12. Beevi S.S., Rasheed M.H., Geetha A. Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin. Chim. Acta 2007, 375:119-123.
13. Marchetti P., Decaudin D., Macho A., Zamzami N., Hirsch T., Susin S.A., Kroemer G. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur. J. Immunol. 1997, 27:289-296.
14. Zamzami N., Marchetti P., Castedo M., Decaudin D., Macho A., Hirsch T., Susin S.A., Petit P.X., Mignotte B., Kroemer G. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 1995, 182:367-377.
15. Singh M., Sharma H., Singh N. Hydrogen peroxide induces apoptosis in HeLa cells through mitochondrial pathway. Mitochondrion 2007, 7:367-373.
16. Brown K.K., Eriksson S.E., Arnér E.S., Hampton M.B. Mitochondrial peroxiredoxin 3 is rapidly oxidized in cells treated with isothiocyanates. Free Radic. Biol. Med. 2008, 45:494-502.
17. De Simoni S., Goemaere J., Knoops B. Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+. Neurosci. Lett. 2008, 433:219-224.
18. Vivas-Mejía P.E., Ozpolat B., Chen X., Lopez-Berestein G. Downregulation of the c-MYC target gene, peroxiredoxin III, contributes to arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Int. J. Cancer 2009, 125:264-275.
19. Cox A.G., Pullar J.M., Hughes G., Ledgerwood E.C., Hampton M.B. Oxidation of mitochondrial peroxiredoxin 3 during the initiation of receptor-mediated apoptosis. Free Radic. Biol. Med. 2008, 44:1001-1009.
20. Shih S.F., Wu Y.H., Hung C.H., H.Y.Yang, Lin J.Y. Abrin triggers cell death by inactivating a thiol-specific antioxidant protein. J. Biol. Chem. 2001, 276:21870-21877.
21. Chang T.S., Cho C.S., Park S., Yu S., Kang S.W., Rhee S.G. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J. Biol. Chem. 2004, 279:41975-41984.